Healthcare -
Biotechnology - NASDAQ - US
$ 13.25
5.16 %
$ 192 M
Market Cap
0.11
P/E
INBX - STOCK-BASED COMPENSATION
Stock-based Compensation INBX - Inhibrx Biosciences, Inc.
24.8 M
LAST VALUE
28.50%
2 YEAR CAGR
58.50%
5 YEAR CAGR
0.00%
10 YEAR CAGR